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Background:  The survival (S) of patients treated with contemporary implantable cardioverter-defibrillators (ICD) is unknown. Such knowledge may 
be valuable for improving ICD therapy. Accordingly we assessed S for ICD patients implanted at our center during the past decade.
Methods:  The records of all patients implanted and followed at our center were reviewed. S were estimated by the Kaplan-Meier method with 95% 
confidence bounds. S were compared using the log rank test.
Results:  Between 2000 and 2009 1555 patients (ALL; mean age: 64.9±14.6 years, and ejection fraction (EF) =31.2%±15.1; 75.2% male, 
69.7% primary prevention) received initial single chamber (18.5%), dual chamber (42.2%) or cardiac resynchronization (39.3%) ICDs. The S for ALL 
patients is in the left panel. The S for patients with hereditary (HCM, channelopathies, ARVD) heart disease (HHD; n=163; EF=57.0%±12.9), dilated 
cardiomyopathy (DCM; n=384; EF=24.7%±10.3), and ischemic cardiomyopathy (ICM; n=902; EF=27.3%±10.4) are in the right panel. The S at 7 
years were: ALL-0.63 (0.59,0.67), HHD-0.88 (0.80,0.96), DCM-0.64 (0.55,0.74), ICM-0.56 (0.52,0.62). S for DCM and ICM were similar (p=0.248) 
but less than HHD (p<0.0001). S for primary vs secondary prevention were not different (p=0.145).
Conclusions:  Our experience suggests most ICM and DCM ICD patients now live >7 years despite severe cardiac disease. Many 
HHD ICD patients could live for decades. These observations underscore the need for long-lived ICD pulse generators and leads. 
